
Dr Reddy's antibiotic gets Thailand approval six months after US nod
The story in brief
Dr Reddy's antibiotic NUZOLVENCE (zoliflodacin) has received approval from Thailand's Food and Drug Administration, six months after US FDA clearance. The drug, a new chemical entity developed through a public-private partnership, is approved for treating uncomplicated urogenital gonorrhoea in adults and children aged 12 and older weighing at least 35 kg. GARDP holds rights to commercialise it in over three-quarters of the world's countries.